应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。
关闭
CRBU Caribou Biosciences
未开盘 03-02 16:00:00 EST
1.84
-0.06
-3.16%
盘后
1.84
+0.00
+0.01%
19:14 EST
最高
1.89
最低
1.76
成交量
114.83万
今开
1.78
昨收
1.90
日振幅
6.58%
总市值
1.72亿
流通市值
1.55亿
总股本
9,347万
成交额
209.28万
换手率
1.37%
流通股本
8,406万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Caribou Biosciences, Inc.盘中异动 早盘股价大跌5.14%报2.03美元
市场透视 · 02-25
Caribou Biosciences, Inc.盘中异动 早盘股价大跌5.14%报2.03美元
Caribou Biosciences, Inc.盘中异动 早盘股价大跌5.13%报1.48美元
市场透视 · 01-16
Caribou Biosciences, Inc.盘中异动 早盘股价大跌5.13%报1.48美元
Caribou Biosciences第三季度许可与合作收入为219.8万美元
投资观察 · 2025-11-20
Caribou Biosciences第三季度许可与合作收入为219.8万美元
Caribou Biosciences报告了关于同种异体CAR T疗法的临床数据，而Kyverna Therapeutics则推进了自身免疫项目Caribou Biosciences Reports Clinical Data on Allogeneic CAR T Therapies While Kyverna Therapeutics Advances Autoimmune Program
动脉网 · 2025-11-05
Caribou Biosciences报告了关于同种异体CAR T疗法的临床数据，而Kyverna Therapeutics则推进了自身免疫项目Caribou Biosciences Reports Clinical Data on Allogeneic CAR T Therapies While Kyverna Therapeutics Advances Autoimmune Program
Caribou推出“今日汽车再融资利率”，开创每日利率资源带来超高透明度
美股速递 · 2025-11-03
Caribou推出“今日汽车再融资利率”，开创每日利率资源带来超高透明度
Caribou Biosciences Inc - 预计截至2025年9月30日的现金和可交易证券为1.592亿美元 - SEC备案
美股速递 · 2025-11-03
Caribou Biosciences Inc - 预计截至2025年9月30日的现金和可交易证券为1.592亿美元 - SEC备案
Caribou Biosciences推荐扩展4.5亿细胞剂量；剂量扩展将在年底前启动，数据预计于2026年公布
美股速递 · 2025-11-03
Caribou Biosciences推荐扩展4.5亿细胞剂量；剂量扩展将在年底前启动，数据预计于2026年公布
Caribou Biosciences公布CB-011在多发性骨髓瘤Cammouflage I期试验中的积极数据
美股速递 · 2025-11-03
Caribou Biosciences公布CB-011在多发性骨髓瘤Cammouflage I期试验中的积极数据
Caribou Biosciences公布Antler I期试验的积极数据，证实Vispa-Cel (CB-010)的疗效和持久性，与自体CAR-T细胞疗法相媲美
美股速递 · 2025-11-03
Caribou Biosciences公布Antler I期试验的积极数据，证实Vispa-Cel (CB-010)的疗效和持久性，与自体CAR-T细胞疗法相媲美
Caribou Biosciences, Inc.盘中异动 快速拉升5.32%报2.97美元
市场透视 · 2025-10-22
Caribou Biosciences, Inc.盘中异动 快速拉升5.32%报2.97美元
Caribou Biosciences, Inc.盘中异动 下午盘急速下挫5.06%报1.69美元
市场透视 · 2025-09-20
Caribou Biosciences, Inc.盘中异动 下午盘急速下挫5.06%报1.69美元
Caribou Biosciences(CRBU.US)：2024年Q4财报实现营收207.7万美元，前值为355.8万美元，预期值为184万美元；每股收益为-0.39美元，前值为-0.39美元，预期值为-0.42美元。
金融界 · 2025-03-11
Caribou Biosciences(CRBU.US)：2024年Q4财报实现营收207.7万美元，前值为355.8万美元，预期值为184万美元；每股收益为-0.39美元，前值为-0.39美元，预期值为-0.42美元。
Caribou生物科学公司2024年第四季度GAAP每股收益$(0.39)，超出预期$(0.42)，销售额$2.08M，未达预期$2.11M
财报速递 · 2025-03-11
Caribou生物科学公司2024年第四季度GAAP每股收益$(0.39)，超出预期$(0.42)，销售额$2.08M，未达预期$2.11M
Caribou Biosciences, Inc.盘中异动 股价大跌5.08%
市场透视 · 2025-03-11
Caribou Biosciences, Inc.盘中异动 股价大跌5.08%
Caribou Biosciences, Inc.盘中异动 下午盘股价大涨5.14%报1.13美元
市场透视 · 2025-03-05
Caribou Biosciences, Inc.盘中异动 下午盘股价大涨5.14%报1.13美元
Caribou Biosciences, Inc.盘中异动 大幅跳水5.13%报1.11美元
市场透视 · 2025-03-04
Caribou Biosciences, Inc.盘中异动 大幅跳水5.13%报1.11美元
Caribou Biosciences, Inc.盘中异动 股价大跌5.24%报1.18美元
市场透视 · 2025-02-27
Caribou Biosciences, Inc.盘中异动 股价大跌5.24%报1.18美元
Caribou Biosciences, Inc.盘中异动 早盘股价大跌6.25%
市场透视 · 2025-02-26
Caribou Biosciences, Inc.盘中异动 早盘股价大跌6.25%
Caribou Biosciences, Inc.盘中异动 急速跳水5.32%报1.34美元
市场透视 · 2025-02-22
Caribou Biosciences, Inc.盘中异动 急速跳水5.32%报1.34美元
Caribou Biosciences, Inc.盘中异动 早盘大幅拉升5.13%报1.42美元
市场透视 · 2025-02-18
Caribou Biosciences, Inc.盘中异动 早盘大幅拉升5.13%报1.42美元
加载更多
公司概况
公司名称：
Caribou Biosciences
所属市场：
NASDAQ
上市日期：
--
主营业务：
Caribou Biosciences, Inc.于2011年10月在特拉华州注册成立。该公司是一家临床阶段的生物制药公司，致力于通过应用该公司的新型CRISPR平台、CRISPR混合RNA-DNA或chRDNA来开发下一代基因组编辑细胞疗法，从而改变患有毁灭性疾病的患者的生活。
发行价格：
--
{"stockData":{"symbol":"CRBU","market":"US","secType":"STK","nameCN":"Caribou Biosciences","latestPrice":1.84,"timestamp":1772485200000,"preClose":1.9,"halted":0,"volume":1148342,"hourTrading":{"tag":"盘后","latestPrice":1.8401,"preClose":1.84,"latestTime":"19:14 EST","volume":48661,"amount":90187.435,"timestamp":1772496886478,"change":0.0001,"changeRate":0.000054,"amplitude":0.021739},"delay":0,"changeRate":-0.03157894736842096,"floatShares":84057626,"shares":93468038,"eps":-1.697865,"marketStatus":"未开盘","change":-0.06,"latestTime":"03-02 16:00:00 EST","open":1.78,"high":1.885,"low":1.76,"amount":2092825.734792,"amplitude":0.065789,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.697865,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1772528400000},"marketStatusCode":0,"adr":0,"listingDate":1627012800000,"exchange":"NASDAQ","adjPreClose":1.9,"preHourTrading":{"tag":"盘前","latestPrice":1.7797,"preClose":1.9,"latestTime":"09:29 EST","volume":36208,"amount":66659.4204288,"timestamp":1772461758697,"change":-0.1203,"changeRate":-0.063316,"amplitude":0.063316},"postHourTrading":{"tag":"盘后","latestPrice":1.8401,"preClose":1.84,"latestTime":"19:14 EST","volume":48661,"amount":90187.435,"timestamp":1772496886478,"change":0.0001,"changeRate":0.000054,"amplitude":0.021739},"volumeRatio":0.494434,"impliedVol":0.9385,"impliedVolPercentile":0.3705},"requestUrl":"/m/hq/s/CRBU","defaultTab":"news","newsList":[{"id":"2614043362","title":"Caribou Biosciences, Inc.盘中异动 早盘股价大跌5.14%报2.03美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2614043362","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614043362?lang=zh_cn&edition=full","pubTime":"2026-02-25 23:25","pubTimestamp":1772033110,"startTime":"0","endTime":"0","summary":"北京时间2026年02月25日23时25分，Caribou Biosciences, Inc.股票出现异动，股价急速下挫5.14%。Caribou Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.22%。其相关个股中，Moolec Science Sa C/Wts 30/01/2028、Larimar Therapeutics, Inc.、Surrozen Inc C/Wts 01/08/2031 涨幅较大，Quince Therapeutics, Inc.、Cardio Diagnostics Holdings Inc.、Genprex, Inc.较为活跃，换手率分别为182.22%、122.92%、34.92%，振幅较大的相关个股有Moolec Science Sa C/Wts 30/01/2028、Larimar Therapeutics, Inc.、曼恩凯德生物医疗，振幅分别为65.42%、49.06%、38.00%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260225232511a4c7c9b4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260225232511a4c7c9b4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRBU","BK4539","BK4139"],"gpt_icon":0},{"id":"2604949432","title":"Caribou Biosciences, Inc.盘中异动 早盘股价大跌5.13%报1.48美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2604949432","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604949432?lang=zh_cn&edition=full","pubTime":"2026-01-16 22:42","pubTimestamp":1768574549,"startTime":"0","endTime":"0","summary":"北京时间2026年01月16日22时42分，Caribou Biosciences, Inc.股票出现波动，股价大幅下挫5.13%。Caribou Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.04%。其相关个股中，Jaguar Health, Inc.、Cingulate Inc C/Wts 10/12/2026 、Immunitybio, Inc.涨幅较大，Jaguar Health, Inc.、Biodexa Pharmaceuticals Plc、Genprex, Inc.较为活跃，换手率分别为895.29%、107.32%、16.35%，振幅较大的相关个股有Moolec Science Sa C/Wts 30/01/2028、Jaguar Health, Inc.、Zura Bio Limited，振幅分别为25.22%、24.85%、16.20%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026011622422997a22372&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026011622422997a22372&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","CRBU"],"gpt_icon":0},{"id":"1130051774","title":"Caribou Biosciences第三季度许可与合作收入为219.8万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1130051774","media":"投资观察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1130051774?lang=zh_cn&edition=full","pubTime":"2025-11-20 01:30","pubTimestamp":1763573405,"startTime":"0","endTime":"0","summary":"11月12日 - Caribou Biosciences第三季度净收入为-2754.8万美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBU","BK4139","BK4539"],"gpt_icon":0},{"id":"2581779056","title":"Caribou Biosciences报告了关于同种异体CAR T疗法的临床数据，而Kyverna Therapeutics则推进了自身免疫项目Caribou Biosciences Reports Clinical Data on Allogeneic CAR T Therapies While Kyverna Therapeutics Advances Autoimmune Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2581779056","media":"动脉网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581779056?lang=zh_cn&edition=full","pubTime":"2025-11-05 16:03","pubTimestamp":1762329780,"startTime":"0","endTime":"0","summary":"Caribou presented findings from trials involving its allogeneic CAR T therapies, which use donor-derived cells rather than a patient’s own cells. These therapies were tested in two separate cancer indications, though specific details regarding efficacy or safety outcomes were not disclosed in the report.Caribou公布了其同种异体CAR T疗法的试验结果，该疗法使用捐赠者来源的细胞而非患者自身的细胞。Meanwhile, Kyverna announced plans to move forward with its CAR T program aimed at treating autoimmune conditions. This marks a shift from the traditional focus of CAR T therapy on oncology and represents an effort to expand the technology’s applications into other therapeutic areas. Both companies continue to explore innovative approaches within this rapidly evolving sector of biotechnology..同时，Kyverna 宣布计划推进其旨在治疗自身免疫性疾病的 CAR T 项目。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110516052697554e2c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110516052697554e2c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4022","BK4139","CAR","BK4230","BK4539","BK4007","CRBU","KYTX"],"gpt_icon":0},{"id":"1149487787","title":"Caribou推出“今日汽车再融资利率”，开创每日利率资源带来超高透明度","url":"https://stock-news.laohu8.com/highlight/detail?id=1149487787","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1149487787?lang=zh_cn&edition=full","pubTime":"2025-11-03 21:47","pubTimestamp":1762177630,"startTime":"0","endTime":"0","summary":"Caribou推出“今日汽车再融资利率”，这是首个每日利率资源，为借款人提供了前所未有的透明度，展现了贷款机构实际提供的利率。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBU","BK4539","BK4139"],"gpt_icon":0},{"id":"1120112545","title":"Caribou Biosciences Inc - 预计截至2025年9月30日的现金和可交易证券为1.592亿美元 - SEC备案","url":"https://stock-news.laohu8.com/highlight/detail?id=1120112545","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1120112545?lang=zh_cn&edition=full","pubTime":"2025-11-03 20:09","pubTimestamp":1762171749,"startTime":"0","endTime":"0","summary":"Caribou Biosciences Inc - 预计截至2025年9月30日的现金和可交易证券为1.592亿美元 - SEC备案","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","CRBU","BK4139"],"gpt_icon":0},{"id":"1151285983","title":"Caribou Biosciences推荐扩展4.5亿细胞剂量；剂量扩展将在年底前启动，数据预计于2026年公布","url":"https://stock-news.laohu8.com/highlight/detail?id=1151285983","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1151285983?lang=zh_cn&edition=full","pubTime":"2025-11-03 20:02","pubTimestamp":1762171334,"startTime":"0","endTime":"0","summary":"Caribou Biosciences推荐扩展4.5亿细胞剂量；剂量扩展将在年底前启动，数据预计于2026年公布","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","CRBU"],"gpt_icon":0},{"id":"1196909115","title":"Caribou Biosciences公布CB-011在多发性骨髓瘤Cammouflage I期试验中的积极数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1196909115","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1196909115?lang=zh_cn&edition=full","pubTime":"2025-11-03 20:01","pubTimestamp":1762171292,"startTime":"0","endTime":"0","summary":"Caribou Biosciences公布CB-011在多发性骨髓瘤Cammouflage I期试验中的积极数据","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","CRBU"],"gpt_icon":0},{"id":"1155001544","title":"Caribou Biosciences公布Antler I期试验的积极数据，证实Vispa-Cel (CB-010)的疗效和持久性，与自体CAR-T细胞疗法相媲美","url":"https://stock-news.laohu8.com/highlight/detail?id=1155001544","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1155001544?lang=zh_cn&edition=full","pubTime":"2025-11-03 20:01","pubTimestamp":1762171278,"startTime":"0","endTime":"0","summary":"Caribou Biosciences公布Antler I期试验的积极数据，证实Vispa-Cel (CB-010)这款全源性CAR-T细胞疗法的疗效和持久性，与自体CAR-T细胞疗法相当。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CRBU","BK4539"],"gpt_icon":0},{"id":"2577330336","title":"Caribou Biosciences, Inc.盘中异动 快速拉升5.32%报2.97美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2577330336","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577330336?lang=zh_cn&edition=full","pubTime":"2025-10-22 00:01","pubTimestamp":1761062471,"startTime":"0","endTime":"0","summary":"北京时间2025年10月22日00时01分，Caribou Biosciences, Inc.股票出现波动，股价大幅拉升5.32%。Caribou Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.35%。其相关个股中，Minerva Neurosciences, Inc、Estrella Immunopharma Inc C/Wts 29/09/2028、Ibio, Inc.涨幅较大，Minerva Neurosciences, Inc、Ibio, Inc.、Rani Therapeutics Holdings, Inc.较为活跃，换手率分别为1877.33%、244.35%、145.90%，振幅较大的相关个股有Minerva Neurosciences, Inc、Cero Therapeutics Holdings Inc C/Wts 14/02/2029 、Ibio, Inc.，振幅分别为215.34%、100.00%、47.03%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025102200011294d61c6d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025102200011294d61c6d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","CRBU","BK4139"],"gpt_icon":0},{"id":"2568976282","title":"Caribou Biosciences, Inc.盘中异动 下午盘急速下挫5.06%报1.69美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2568976282","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568976282?lang=zh_cn&edition=full","pubTime":"2025-09-20 02:31","pubTimestamp":1758306710,"startTime":"0","endTime":"0","summary":"北京时间2025年09月20日02时31分，Caribou Biosciences, Inc.股票出现异动，股价急速下挫5.06%。Caribou Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.54%。其相关个股中，Klotho Neurosciences Inc C/Wts 21/06/2029 、Protagenic Therapeutics Inc C/Wts 26/04/2026 、Adverum Biotechnologies, Inc.涨幅较大，Clearmind Medicine Inc.、Adaptimmune Therapeutics Plc、Aptevo Therapeutics Inc.较为活跃，换手率分别为675.49%、183.81%、165.75%，振幅较大的相关个股有Adaptimmune Therapeutics Plc、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Sab Biotherapeutics Inc C/Wts 22/10/2026 ，振幅分别为65.63%、59.00%、43.54%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250920023151953911ac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250920023151953911ac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRBU","BK4539","BK4139"],"gpt_icon":0},{"id":"2518778948","title":"Caribou Biosciences(CRBU.US)：2024年Q4财报实现营收207.7万美元，前值为355.8万美元，预期值为184万美元；每股收益为-0.39美元，前值为-0.39美元，预期值为-0.42美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2518778948","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518778948?lang=zh_cn&edition=full","pubTime":"2025-03-11 05:45","pubTimestamp":1741643101,"startTime":"0","endTime":"0","summary":"Caribou Biosciences(CRBU.US)：2024年Q4财报实现营收207.7万美元，前值为355.8万美元，预期值为184万美元；每股收益为-0.39美元，前值为-0.39美元，预期值为-0.42美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/11054548643209.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["CRBU"],"gpt_icon":0},{"id":"1196872356","title":"Caribou生物科学公司2024年第四季度GAAP每股收益$(0.39)，超出预期$(0.42)，销售额$2.08M，未达预期$2.11M","url":"https://stock-news.laohu8.com/highlight/detail?id=1196872356","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1196872356?lang=zh_cn&edition=full","pubTime":"2025-03-11 04:14","pubTimestamp":1741637684,"startTime":"0","endTime":"0","summary":"Caribou生物科学公司报告季度每股亏损$，比分析师普遍预期的$高7.14%。该公司报告季度销售额为$208万美元，未达分析师普遍预期的$211万美元，差距为1.39%。这比去年同期的$356万美元下降了41.62%。以上内容来自Benzinga Earnings专栏，原文如下：$Caribou Biosciences$ reported quarterly losses of $ per share which beat the analyst consensus estimate of $ by 7.14 percent. This is unchanged from the same period last year. The company reported quarterly sales of $2.08 million which missed the analyst consensus estimate of $2.11 million by 1.39 percent. This is a 41.62 percent decrease over sales of ","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Caribou生物科学公司2024年第四季度GAAP每股收益$(0.39)，超出预期$(0.42)，销售额$2.08M，未达预期$2.11M","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBU"],"gpt_icon":0},{"id":"2518820578","title":"Caribou Biosciences, Inc.盘中异动 股价大跌5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518820578","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518820578?lang=zh_cn&edition=full","pubTime":"2025-03-11 00:58","pubTimestamp":1741625882,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日00时58分，Caribou Biosciences, Inc.股票出现波动，股价急速跳水5.08%。Caribou Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.86%。Caribou Biosciences, Inc.公司简介：Caribou Biosciences Inc 是一家临床阶段的 Clustered Regularly Interspaced Short Palindromic Repeats 生物制药公司，致力于通过应用其新型 CRISPR 平台， CRISPR 杂交 RNA-DNA 来改变患有毁灭性疾病患者的生活，以开发下一代药物 代、基因组编辑的细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311005802abf347a4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311005802abf347a4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRBU","BK4139","BK4539"],"gpt_icon":0},{"id":"2517398387","title":"Caribou Biosciences, Inc.盘中异动 下午盘股价大涨5.14%报1.13美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517398387","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517398387?lang=zh_cn&edition=full","pubTime":"2025-03-05 03:26","pubTimestamp":1741116374,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日03时26分，Caribou Biosciences, Inc.股票出现异动，股价大幅上涨5.14%。截至发稿，该股报1.13美元/股，成交量99.5745万股，换手率1.10%，振幅10.09%。Caribou Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.12%。Caribou Biosciences, Inc.公司简介：Caribou Biosciences Inc 是一家临床阶段的 Clustered Regularly Interspaced Short Palindromic Repeats 生物制药公司，致力于通过应用其新型 CRISPR 平台， CRISPR 杂交 RNA-DNA 来改变患有毁灭性疾病患者的生活，以开发下一代药物 代、基因组编辑的细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305032614abe84144&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305032614abe84144&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","CRBU","BK4139"],"gpt_icon":0},{"id":"2516654565","title":"Caribou Biosciences, Inc.盘中异动 大幅跳水5.13%报1.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516654565","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516654565?lang=zh_cn&edition=full","pubTime":"2025-03-04 02:18","pubTimestamp":1741025929,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日02时18分，Caribou Biosciences, Inc.股票出现异动，股价快速跳水5.13%。Caribou Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.09%。其相关个股中，Bioxcel Therapeutics, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 、Radiopharm Theranostics Limited涨幅较大，Bioxcel Therapeutics, Inc.、Allarity Therapeutics, Inc.、Entero Therapeutics Inc.较为活跃，换手率分别为4364.36%、190.31%、179.16%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Radiopharm Theranostics Limited、Entero Therapeutics Inc.，振幅分别为206.20%、119.50%、70.53%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503040218499637e0fe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503040218499637e0fe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRBU","BK4139","BK4539"],"gpt_icon":0},{"id":"2514361862","title":"Caribou Biosciences, Inc.盘中异动 股价大跌5.24%报1.18美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514361862","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514361862?lang=zh_cn&edition=full","pubTime":"2025-02-27 04:11","pubTimestamp":1740600700,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日04时11分，Caribou Biosciences, Inc.股票出现异动，股价急速跳水5.24%。Caribou Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.78%。其相关个股中，Enveric Biosciences, Inc.、Renovaro Inc.、Geovax Labs Inc C/Wts 29/09/2025涨幅较大，Enveric Biosciences, Inc.、Aeon Biopharma, Inc.、Organovo Holdings, Inc.较为活跃，换手率分别为6793.62%、321.58%、263.67%，振幅较大的相关个股有Enveric Biosciences, Inc.、Renovaro Inc.、Immatics N V C/Wts 01/07/2025 ，振幅分别为194.07%、81.11%、70.39%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227041140a2554242&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227041140a2554242&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CRBU","BK4539"],"gpt_icon":0},{"id":"2514781019","title":"Caribou Biosciences, Inc.盘中异动 早盘股价大跌6.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514781019","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514781019?lang=zh_cn&edition=full","pubTime":"2025-02-26 00:13","pubTimestamp":1740500039,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日00时13分，Caribou Biosciences, Inc.股票出现波动，股价急速下挫6.25%。Caribou Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.53%。Caribou Biosciences, Inc.公司简介：Caribou Biosciences Inc 是一家临床阶段的 Clustered Regularly Interspaced Short Palindromic Repeats 生物制药公司，致力于通过应用其新型 CRISPR 平台， CRISPR 杂交 RNA-DNA 来改变患有毁灭性疾病患者的生活，以开发下一代药物 代、基因组编辑的细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226001359a2539e83&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226001359a2539e83&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","CRBU","BK4139"],"gpt_icon":0},{"id":"2513133372","title":"Caribou Biosciences, Inc.盘中异动 急速跳水5.32%报1.34美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513133372","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513133372?lang=zh_cn&edition=full","pubTime":"2025-02-22 01:35","pubTimestamp":1740159331,"startTime":"0","endTime":"0","summary":"北京时间2025年02月22日01时35分，Caribou Biosciences, Inc.股票出现波动，股价大幅下挫5.32%。Caribou Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.35%。Caribou Biosciences, Inc.公司简介：Caribou Biosciences Inc 是一家临床阶段的 Clustered Regularly Interspaced Short Palindromic Repeats 生物制药公司，致力于通过应用其新型 CRISPR 平台， CRISPR 杂交 RNA-DNA 来改变患有毁灭性疾病患者的生活，以开发下一代药物 代、基因组编辑的细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222013531a24ed815&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222013531a24ed815&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRBU","BK4139","BK4539"],"gpt_icon":0},{"id":"2512166417","title":"Caribou Biosciences, Inc.盘中异动 早盘大幅拉升5.13%报1.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512166417","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512166417?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:50","pubTimestamp":1739890216,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时50分，Caribou Biosciences, Inc.股票出现异动，股价快速上涨5.13%。Caribou Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.96%。Caribou Biosciences, Inc.公司简介：Caribou Biosciences Inc 是一家临床阶段的 Clustered Regularly Interspaced Short Palindromic Repeats 生物制药公司，致力于通过应用其新型 CRISPR 平台， CRISPR 杂交 RNA-DNA 来改变患有毁灭性疾病患者的生活，以开发下一代药物 代、基因组编辑的细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021822501696279b4b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021822501696279b4b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","CRBU"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cariboubio.com","stockEarnings":[{"period":"1week","weight":-0.0417},{"period":"1month","weight":0.305},{"period":"3month","weight":0.0455},{"period":"6month","weight":-0.0265},{"period":"1year","weight":0.5726},{"period":"ytd","weight":0.1572}],"compareEarnings":[{"period":"1week","weight":0.0058},{"period":"1month","weight":-0.0081},{"period":"3month","weight":0.0071},{"period":"6month","weight":0.0662},{"period":"1year","weight":0.1552},{"period":"ytd","weight":0.0065}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Caribou Biosciences, Inc.于2011年10月在特拉华州注册成立。该公司是一家临床阶段的生物制药公司，致力于通过应用该公司的新型CRISPR平台、CRISPR混合RNA-DNA或chRDNA来开发下一代基因组编辑细胞疗法，从而改变患有毁灭性疾病的患者的生活。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.056975},{"month":2,"riseRate":0.4,"avgChangeRate":0.046168},{"month":3,"riseRate":0,"avgChangeRate":-0.161916},{"month":4,"riseRate":0,"avgChangeRate":-0.1865},{"month":5,"riseRate":0.75,"avgChangeRate":0.047596},{"month":6,"riseRate":0.25,"avgChangeRate":-0.156574},{"month":7,"riseRate":1,"avgChangeRate":0.553226},{"month":8,"riseRate":0.4,"avgChangeRate":0.113188},{"month":9,"riseRate":0.4,"avgChangeRate":-0.017718},{"month":10,"riseRate":0.2,"avgChangeRate":-0.070494},{"month":11,"riseRate":0.4,"avgChangeRate":0.066546},{"month":12,"riseRate":0,"avgChangeRate":-0.198393}],"exchange":"NASDAQ","name":"Caribou Biosciences","nameEN":"Caribou Biosciences"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Caribou Biosciences(CRBU)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Caribou Biosciences(CRBU)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Caribou Biosciences,CRBU,Caribou Biosciences股票,Caribou Biosciences股票老虎,Caribou Biosciences股票老虎国际,Caribou Biosciences行情,Caribou Biosciences股票行情,Caribou Biosciences股价,Caribou Biosciences股市,Caribou Biosciences股票价格,Caribou Biosciences股票交易,Caribou Biosciences股票购买,Caribou Biosciences股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Caribou Biosciences(CRBU)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Caribou Biosciences(CRBU)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}